|
Volumn 792, Issue 2, 2003, Pages 323-332
|
Isolation of an unknown metabolite of capecitabine, an oral 5-fluorouracil prodrug, and its identification by nuclear magnetic resonance and liquid chromatography-tandem mass spectrometry as a glucuroconjugate of 5′-deoxy-5-fluorocytidine, namely 2′-(β-D-glucuronic acid)-5′-deoxy-5-fluorocytidine
|
Author keywords
5 Fluorouracil; 5 Deoxy 5 fluorocytidine; Capecitabine
|
Indexed keywords
DRUG PRODUCTS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
METABOLITES;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
SEPARATION;
TUMORS;
LIQUID-LIQUID SEPARATION;
BIOMEDICAL ENGINEERING;
2' (BETA DEXTRO GLUCURONIC ACID) 5' DEOXY 5 FLUOROCYTIDINE;
5' DEOXY 5 FLUOROCYTIDINE;
ANTINEOPLASTIC AGENT;
BETA GLUCURONIDASE;
CAPECITABINE;
CHEMICAL COMPOUND;
CHLORIDE;
CYTIDINE DERIVATIVE;
FLUOROURACIL;
OCTADECYLSILANE;
PRODRUG;
SILANE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ARTICLE;
COLUMN CHROMATOGRAPHY;
CONJUGATION;
CONTROLLED STUDY;
DRUG PURIFICATION;
FLUORINATION;
GLUCURONIDATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
LIQUID CHROMATOGRAPHY;
MALE;
MASS SPECTROMETRY;
METABOLITE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
TANDEM MASS SPECTROMETRY;
|
EID: 0037969390
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S1570-0232(03)00319-2 Document Type: Article |
Times cited : (9)
|
References (6)
|